The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 340:314-315 January 28, 1999 Number 4
NextNext

Does a Low Level of Expression of HLA Molecules Engender Autoimmunity?

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Handgretinger, R.
-PubMed Citation
The immune system can summon a variety of defenses against invaders from the outside. Among these deterrents are three types of killer lymphocytes that attack and lyse cellular targets. One type consists of cytotoxic, or CD8, T cells with {alpha} antigen receptors that interact with the HLA class I glycoproteins on nearly all cells. These HLA molecules bind to peptides derived from intracellular antigens, such as viral proteins, and display them on the cell surface. Binding of the {alpha}/ß antigen receptor to complexes of HLA class I molecules and peptide fragments of an invading virus induces the T lymphocyte to . . . [Full Text of this Article]

References


Related Letters:

Pure Red-Cell Aplasia
Nathan D. G., Sieff C. A., Zimmer J., Regele D., de la Salle H., Handgretinger R., Fisch P.
Extract | Full Text  
N Engl J Med 1999; 340:2004-2005, Jun 24, 1999. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.